GutCRINE made the headlines at this leading nordic life science news website: https://nordiclifescience.org/gutcrine-first-investment-from-the-university-of-copenhagens-new-investment-company/
A randomised clinical trial testing the safety of and metabolic responses to short-term duodenal infusion of recombinant RORDEP1 in healthy men
We are excited to share this article in Springer Nature. Here is the link to the article: https://link.springer.com/article/10.1007/s00125-026-06751-0
